135 related articles for article (PubMed ID: 36279941)
1. The establishment and validation of reference intervals for plasma Pentraxin-3 in healthy volunteers and patients with Takayasu's arteritis.
Zhou X; Han Q; Wang X; Zhang M; Li X; Ma W; Wang X; Yang W; Zhu P; Wang J; Kang F
Clin Chim Acta; 2022 Dec; 537():146-153. PubMed ID: 36279941
[TBL] [Abstract][Full Text] [Related]
2. Study on the association of serum pentraxin-3 and lysosomal-associated membrane protein-2 levels with disease activity in Chinese Takayasu's arteritis patients.
Chen Z; Hu C; Sun F; Li J; Yang Y; Tian X; Zeng X
Clin Exp Rheumatol; 2019; 37 Suppl 117(2):109-115. PubMed ID: 30943132
[TBL] [Abstract][Full Text] [Related]
3. Performance of the PET vascular activity score (PETVAS) for qualitative and quantitative assessment of inflammatory activity in Takayasu's arteritis patients.
Kang F; Han Q; Zhou X; Zheng Z; Wang S; Ma W; Zhang K; Quan Z; Yang W; Wang J; Zhu P
Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3107-3117. PubMed ID: 32567005
[TBL] [Abstract][Full Text] [Related]
4. Plasma pentraxin-3 levels in patients with Takayasu's arteritis during routine follow-up.
Alibaz-Oner F; Aksu K; Yentur SP; Keser G; Saruhan-Direskeneli G; Direskeneli H
Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S73-6. PubMed ID: 26885720
[TBL] [Abstract][Full Text] [Related]
5. Patients with Takayasu's arteritis having persistent acute-phase response usually have an increased major vessel uptake by 18F-FDG-PET/CT.
Alibaz-Oner F; Dede F; Ones T; Turoglu HT; Direskeneli H
Mod Rheumatol; 2015 Sep; 25(5):752-5. PubMed ID: 25671403
[TBL] [Abstract][Full Text] [Related]
6. Pentraxin-3 as a marker of disease activity in Takayasu arteritis.
Dagna L; Salvo F; Tiraboschi M; Bozzolo EP; Franchini S; Doglioni C; Manfredi AA; Baldissera E; Sabbadini MG
Ann Intern Med; 2011 Oct; 155(7):425-33. PubMed ID: 21969341
[TBL] [Abstract][Full Text] [Related]
7. Serum cytokine profiles in Takayasu's arteritis: search for biomarkers.
Alibaz-Oner F; Yentür SP; Saruhan-Direskeneli G; Direskeneli H
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-32-5. PubMed ID: 25436391
[TBL] [Abstract][Full Text] [Related]
8. IL-9-producing Th9 cells may participate in pathogenesis of Takayasu's arteritis.
Pan LL; Du J; Gao N; Liao H; Wan J; Ci WP; Yang C; Wang T
Clin Rheumatol; 2016 Dec; 35(12):3031-3036. PubMed ID: 27629397
[TBL] [Abstract][Full Text] [Related]
9. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio associated with disease activity in patients with Takayasu's arteritis: a case-control study.
Pan L; Du J; Li T; Liao H
BMJ Open; 2017 May; 7(4):e014451. PubMed ID: 28473512
[TBL] [Abstract][Full Text] [Related]
10. Lack of antilipoprotein lipase antibodies in Takayasu's arteritis.
de Carvalho JF; Pereira RM; Viana VS; Bonfá E; Shoenfeld Y
Clin Dev Immunol; 2009; 2009():803409. PubMed ID: 19606253
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum 25-hydroxyvitamin D: a potential indicator of remission in Takayasu arteritis patients with normal ESR and CRP levels.
Liao H; Du J; Li F; Yang S; Qi G; Pan L
Clin Rheumatol; 2024 Jun; 43(6):1979-1987. PubMed ID: 38598024
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of B cells and immunoglobulin profile in Takayasu's arteritis.
Ci W; Li T; Du J; Fang W; Chen D; Han L; Dong R; Cao J; Pan L
Clin Exp Rheumatol; 2023 Apr; 41(4):870-878. PubMed ID: 36533979
[TBL] [Abstract][Full Text] [Related]
13. AMPK hyperactivity maintains the survival of vasculogenic T cells in patients with Takayasu's arteritis.
Sun M; Zhang X; Hao Y; Yin P; Hu J; Zheng M; Wen Z; Liu X; Wang C
Clin Exp Rheumatol; 2023 Apr; 41(4):902-909. PubMed ID: 36826789
[TBL] [Abstract][Full Text] [Related]
14. [Fundus manifestation and treatment of Takayasu's arteritis].
Wang WW; Ye JJ; Chen YX; Dai RP
Zhonghua Yan Ke Za Zhi; 2012 Feb; 48(2):124-30. PubMed ID: 22490947
[TBL] [Abstract][Full Text] [Related]
15. Risk assessment model for heart failure in Chinese patients with Takayasu's arteritis.
Wang YJ; Ma LL; Liu Y; Yan Y; Sun Y; Wang YS; Dai XM; Ji ZF; Ma LY; Chen HY; Jiang LD
Clin Rheumatol; 2021 Oct; 40(10):4117-4126. PubMed ID: 34021842
[TBL] [Abstract][Full Text] [Related]
16. Anaemia can be improved by controlling the disease activity of Takayasu's arteritis without iron administration.
Guo Y; Du J; Li T; Gao N; Pan L
Int J Lab Hematol; 2023 Feb; 45(1):112-118. PubMed ID: 36117441
[TBL] [Abstract][Full Text] [Related]
17. Assessment of inflammatory activity in Takayasu's arteritis: performance of clinical scores and common biomarkers versus 18F-FDG PET/CT.
Jiménez D; Soto ME; Martínez-Martínez LA; Hernández-López D; Lerma C; Barragán-Garfias JA; Pérez-Torres I; Hernández-Lemus E; Guarner-Lans V
Clin Exp Rheumatol; 2021; 39(5):1011-1020. PubMed ID: 33124558
[TBL] [Abstract][Full Text] [Related]
18. Value of whole-body contrast-enhanced magnetic resonance angiography with vessel wall imaging in quantitative assessment of disease activity and follow-up examination in Takayasu's arteritis.
Sun Y; Ma L; Ji Z; Zhang Z; Chen H; Liu H; Shan Y; Yan F; Jiang L
Clin Rheumatol; 2016 Mar; 35(3):685-93. PubMed ID: 25665823
[TBL] [Abstract][Full Text] [Related]
19. Pentraxin 3 is more accurate than C-reactive protein for Takayasu arteritis activity assessment: A systematic review and meta-analysis.
Wen X; Hou R; Xu K; Han Y; Hu J; Zhang Y; Su Y; Gao J; Zhang G; Zhang L
PLoS One; 2021; 16(2):e0245612. PubMed ID: 33529185
[TBL] [Abstract][Full Text] [Related]
20. Using the co-expression network of T cell-activation-related genes to assess the disease activity in Takayasu's arteritis patients.
Tian Y; Li J; Tian X; Zeng X
Arthritis Res Ther; 2021 Dec; 23(1):303. PubMed ID: 34915894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
